Histomolecular characterisation of hepatitis B virus induced liver cancer

Rev Med Virol. 2023 Nov;33(6):e2485. doi: 10.1002/rmv.2485. Epub 2023 Oct 30.

Abstract

Hepatitis B virus (HBV)-associated liver cancer is the third most prevalent cancer-related cause of death worldwide. Different studies have been done on the histomolecular analysis of HBV induced-liver cancer including epigenetics which are dynamic molecular mechanisms to control gene expression without altering the host deoxyribonucleic acid, genomics characterise the integration of the viral genome with host genome, proteomics characterise how gene modifies and results overexpression of proteins, glycoproteomics discover different glyco-biomarker candidates and show glycosylation in malignant hepatocytes, metabolomics characterise how HBV impairs a variety of metabolic functions during hepatocyte immortalisation, exosomes characterise immortalised liver cells in terms of their differentiation and proliferation, and autophagy plays a role in the development of hepatocarcinogenesis linked to HBV infection.

Keywords: hepatitis B virus; histomolecular characterisations; liver cancer.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Genome, Viral
  • Hepatitis B virus / genetics
  • Hepatitis B* / complications
  • Hepatitis B* / genetics
  • Hepatocytes / pathology
  • Humans
  • Liver Neoplasms*